Skip to main content
Fig. 6 | Journal of Hematology & Oncology

Fig. 6

From: Novel roles of DC-SIGNR in colon cancer cell adhesion, migration, invasion, and liver metastasis

Fig. 6

Soluble DC-SIGNR is significantly upregulated in colon cancer patients with liver metastasis. The serum levels of DC-SIGNR were detected by an enzyme-linked immunosorbent assay. a The scatter plot shows the comparison of serum DC-SIGNR levels between patients with stage III/IV colon cancer and healthy individuals. The level of serum DC-SIGNR was significantly higher in patients with stage III/IV colon cancer compared with healthy controls (P < 0.0001). b Comparison of DC-SIGNR levels in colon cancer patients with liver metastasis and those without metastasis. The serum DC-SIGNR level was statistically higher in colon cancer patients with liver metastasis than those without metastasis (P = 0.0258). The error bars in all graphs represent SD

Back to article page